These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 7713475

  • 1. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D, Krone W.
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [Abstract] [Full Text] [Related]

  • 2. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism].
    Krone W, Müller-Wieland D, Wirth H.
    Fortschr Med; 1992 Dec 10; 110(34):645-8. PubMed ID: 1483617
    [Abstract] [Full Text] [Related]

  • 3. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Dec 10; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM.
    Panminerva Med; 2005 Dec 10; 47(4):201-10. PubMed ID: 16489319
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 10; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 6. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov 10; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 7. Diabetic dyslipidaemia.
    Erkelens DW.
    Eur Heart J; 1998 Jul 10; 19 Suppl H():H27-40. PubMed ID: 9717062
    [Abstract] [Full Text] [Related]

  • 8. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
    McKenney JM.
    Pharmacotherapy; 1993 Jul 10; 13(4):340-52. PubMed ID: 8361860
    [Abstract] [Full Text] [Related]

  • 9. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
    Goff DC, D'Agostino RB, Haffner SM, Otvos JD.
    Metabolism; 2005 Feb 10; 54(2):264-70. PubMed ID: 15690322
    [Abstract] [Full Text] [Related]

  • 10. [The significance of insulin resistance and hyperlipidemia in microvascular angina (syndrome X)].
    Langes K, Volk C, Schneider MA, Koschyk DH, Rinninger F, Nienaber CA.
    Z Kardiol; 1995 Mar 10; 84(3):180-9. PubMed ID: 7732710
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 10; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 12. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW.
    Curr Med Res Opin; 2001 Dec 10; 17(1):60-73. PubMed ID: 11464448
    [Abstract] [Full Text] [Related]

  • 13. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H, Goyal RK.
    Indian Heart J; 2001 Dec 10; 53(2):172-6. PubMed ID: 11428472
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec 10; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 15. Lipid and lipoprotein dysregulation in insulin resistant states.
    Avramoglu RK, Basciano H, Adeli K.
    Clin Chim Acta; 2006 Jun 10; 368(1-2):1-19. PubMed ID: 16480697
    [Abstract] [Full Text] [Related]

  • 16. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul 10; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 17. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R, Borggreve SE, Dullaart RP.
    Clin Lab; 2003 Jul 10; 49(11-12):601-13. PubMed ID: 14651331
    [Abstract] [Full Text] [Related]

  • 18. [Non-pharmacological therapy of metabolic syndrome].
    Wirth A.
    Herz; 1995 Feb 10; 20(1):56-69. PubMed ID: 7713478
    [Abstract] [Full Text] [Related]

  • 19. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C, Watanabe T, Zhang Y, Trigatti B, Szeto L, Connelly PW, Marcovina S, Vaisar T, Heinecke JW, Lewis GF.
    Circ Res; 2008 Jul 18; 103(2):159-66. PubMed ID: 18556574
    [Abstract] [Full Text] [Related]

  • 20. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 18; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.